Overview

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial of LCB01-0371.
Phase:
Phase 2
Details
Lead Sponsor:
LegoChem Biosciences, Inc
Treatments:
Delpazolid
Linezolid
Oxazolidinones